KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,925,490 | -33.1% | 2,183,201 | -10.7% | 0.01% | -33.3% |
| Q2 2023 | $4,374,755 | -43.3% | 2,443,997 | +23.1% | 0.01% | -43.8% |
| Q1 2023 | $7,721,284 | +2.7% | 1,984,906 | -10.2% | 0.02% | -5.9% |
| Q4 2022 | $7,514,759 | +765.8% | 2,210,223 | +1288.9% | 0.02% | +750.0% |
| Q3 2022 | $868,000 | +742.7% | 159,137 | +591.9% | 0.00% | – |
| Q2 2022 | $103,000 | +80.7% | 23,000 | +155.4% | 0.00% | – |
| Q4 2021 | $57,000 | -98.3% | 9,006 | -95.9% | 0.00% | -100.0% |
| Q4 2020 | $3,366,000 | +1124.0% | 217,430 | +1053.8% | 0.02% | +800.0% |
| Q3 2020 | $275,000 | -95.1% | 18,845 | -93.6% | 0.00% | -94.9% |
| Q4 2019 | $5,645,000 | – | 294,512 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |